Cargando…
In silico mouse study identifies tumour growth kinetics as biomarkers for the outcome of anti-angiogenic treatment
Angiogenesis is a crucial step in tumour progression, as this process allows tumours to recruit new blood vessels and obtain oxygen and nutrients to sustain growth. Therefore, inhibiting angiogenesis remains a viable strategy for cancer therapy. However, anti-angiogenic therapy has not proved to be...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal Society
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127173/ https://www.ncbi.nlm.nih.gov/pubmed/30135261 http://dx.doi.org/10.1098/rsif.2018.0243 |